These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8519281)

  • 1. Mechanisms of action in the liver of crilvastatin, a new hydroxymethylglutaryl-coenzyme A reductase inhibitor.
    Clerc T; Jomier M; Chautan M; Portugal H; Senft M; Pauli AM; Laruelle C; Morel O; Lafont H; Chanussot F
    Eur J Pharmacol; 1993 Apr; 235(1):59-68. PubMed ID: 8519281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Hajri T; Chanussot F; Férézou J; Riottot M; Lafont H; Laruelle C; Lutton C
    Eur J Pharmacol; 1997 Feb; 320(1):65-71. PubMed ID: 9049604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of crilvastatin, a new cholesterol lowering agent, on unesterified LDL-cholesterol metabolism into bile salts by rat isolated hepatocytes.
    Clerc T; Sbarra V; Diaconescu N; Lafont H; Jadot G; Laruelle C; Chanussot F
    Br J Pharmacol; 1995 Feb; 114(3):624-31. PubMed ID: 7735689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats.
    Hajri T; Férézou J; Laruelle C; Lutton C
    Eur J Pharmacol; 1995 Nov; 286(2):131-6. PubMed ID: 8605949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.
    Clerc T; Sbarra V; Domingo N; Rault JP; Diaconescu N; Moutardier V; Hasselot N; Lafont H; Jadot G; Laruelle C; Chanussot F
    Br J Pharmacol; 1996 Aug; 118(7):1862-8. PubMed ID: 8842455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
    Matsui S; Yamane T; Takita T; Oishi Y; Kobayashi-Hattori K
    Nutr Res; 2013 Jul; 33(7):580-5. PubMed ID: 23827133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single administration of pravastatin sodium on hepatic cholesterol metabolism in rats.
    Fujioka T; Tsujita Y
    Eur J Pharmacol; 1997 Apr; 323(2-3):223-8. PubMed ID: 9128842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats.
    Rodríguez-Páez L; Juárez-Sanchez M; Antúnez-Solís J; Baeza I; Wong C
    Phytomedicine; 2003; 10(5):397-404. PubMed ID: 12834005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocholesterolemic activity of cornelian cherry (Cornus mas L.) fruits.
    Hosseinpour F; Shomali T; Rafieian-Kopaei M
    J Complement Integr Med; 2017 Jun; 14(4):. PubMed ID: 28731315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CS-514, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in hamsters.
    Koide K; Hayashi K; Horiuchi I; Kajiyama G
    Biochim Biophys Acta; 1989 Sep; 1005(1):65-71. PubMed ID: 2505850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-coa reductase inhibitors.
    Hiyoshi H; Yanagimachi M; Ito M; Ohtsuka I; Yoshida I; Saeki T; Tanaka H
    J Lipid Res; 2000 Jul; 41(7):1136-44. PubMed ID: 10884296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocholesterolemic effect of physically refined rice bran oil: studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters.
    Ausman LM; Rong N; Nicolosi RJ
    J Nutr Biochem; 2005 Sep; 16(9):521-9. PubMed ID: 16115540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocholesterolemic effect of stilbenes containing extract-fraction from Cajanus cajan L. on diet-induced hypercholesterolemia in mice.
    Luo QF; Sun L; Si JY; Chen DH
    Phytomedicine; 2008 Nov; 15(11):932-9. PubMed ID: 18420398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,4,5-trimethoxycinnamic acid: the major metabolite of alpha-asarone, retains most of the pharmacological properties of alpha-asarone.
    Antunez-Solis J; Hernández-Derramadero F; Aquino-Vega M; Ibarra-Ramírez S; Rodríguez-Páez L; Baeza I; Wong C
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):903-9. PubMed ID: 18686138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits.
    Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Tint GS; Parker TS; Roberts J; Batta AK; Chen TS; Zhao Z; Kong X
    Hepatology; 1996 Oct; 24(4):882-7. PubMed ID: 8855192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.